Hinweis-Modus ist eingeschaltet Ausschalten

HELX - Franklin Genomic Advancements ETF (USD) (US35473P5200)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen
 
(%)
US35473P5200
HELX ISIN
Exchange Traded Funds (ETF)
Fondstyp
Franklin Templeton Investments
Anbieter
35,73 USD
NAV pro Aktie | 04/06/2026
25/02/2020
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOJLS
CFI
HELX
Ticker
Formed
Status
Equity
Investitionsobjekt
Biotech
Sektor
USA
Geographie
Russell 3000 Index
Benchmark
0.5 %
Gesamtkostenquote
23,22 Mio. USD
Gesamtes Fondsvermögen | 04/06/2026
23,22 Mio. USD
Aktien-Anlageklasse Volumen | 04/06/2026
Nein
UCITS

Rendite auf 05/06/2026, Cboe BZX Exchange

  • YTD
    -10,83 %
  • 1M
    -6,62 %
  • 3M
    -7,6 %
  • 6M
    -7,55 %
  • 1J
    24,21 %
  • 3J
    9 %
  • 5J
    -21,11 %
  • 10J
    -
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen
von
zu
ADD-IN
Cbonds Add-In API
API Anleihen-Daten

Kurse (HELX)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In
Zugang erhalten

Kurs-Dynamik

HELX profile

The Franklin Genomic Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Franklin Templeton Investments fund’s base currency is USD and the share class was registered 25.02.2020 with unique ISIN - US35473P5200. Main exchange is Cboe BZX Exchange and ticker symbol is HELX. The total expense ratio is 0.5%. The Franklin Genomic Advancements ETF (USD) pays dividends 1 time(s) per year.

Struktur HELX auf 04/06/2026

Struktur in Excel herunterladen
Wertpapier Wertpapier
GUARDANT HEALTH INC GH 9,01%
NATERA INC NTRA 6,82%
KRYSTAL BIOTECH INC KRYS 5,86%
UNITED THERAPEUTICS CORP UTHR 3,96%
LIGAND PHARMACEUTICALS LGND 3,85%
ADAPTIVE BIOTECHNOLOGIES ADPT 3,76%
BRIDGEBIO PHARMA INC BBIO 3,53%
ELI LILLY & CO LLY 3,1%
ASTRAZENECA PLC AZN 2,89%
VERTEX PHARMACEUTICALS IN VRTX 2,73%
INSMED INC INSM 2,68%
SAMSUNG BIOLOGICS CO LTD 207940 2,48%
CORTEVA INC CTVA 2,3%
TWIST BIOSCIENCE CORP TWST 2,29%
ALNYLAM PHARMACEUTICALS I ALNY 2,21%
CASH — 2,21%
TRAVERE THERAPEUTICS INC TVTX 2,14%
MEDPACE HOLDINGS INC MEDP 2,08%
NEUROCRINE BIOSCIENCES IN NBIX 2,05%
REGENERON PHARMACEUTICALS REGN 2,03%
IONIS PHARMACEUTICALS INC IONS 2,02%
TEMPUS AI INC-CL A TEM 1,96%
ARGENX SE ARGX 1,68%
VERACYTE INC VCYT 1,56%
BIONTECH SE-ADR BNTX 1,49%
PTC THERAPEUTICS INC PTCT 1,42%
STOKE THERAPEUTICS INC STOK 1,37%
GRAIL INC GRAL 1,19%
CADENCE DESIGN SYS INC CDNS 1,19%
CHARLES RIVER LABORATORIE CRL 1,16%
CRISPR THERAPEUTICS AG CRSP 1,15%
SARTORIUS AG-VORZUG SRT3 1,05%
REPLIGEN CORP RGEN 1,02%
BEAM THERAPEUTICS INC BEAM 0,99%
ANAPTYSBIO INC ANAB 0,89%
JAZZ PHARMACEUTICALS PLC JAZZ 0,87%
AXSOME THERAPEUTICS INC AXSM 0,87%
CATALYST PHARMACEUTICALS CPRX 0,86%
IQVIA HOLDINGS INC IQV 0,81%
THERMO FISHER SCIENTIFIC TMO 0,81%
PRAXIS PRECISION MEDICINE PRAX 0,76%
CAREDX INC CDNA 0,74%
AGILENT TECHNOLOGIES INC A 0,68%
DANAHER CORP DHR 0,63%
HINGE HEALTH INC-A HNGE 0,59%
QIAGEN N.V. — 0,51%
ULTRAGENYX PHARMACEUTICAL RARE 0,48%
SAMSUNG EPISHOLDINGS CO L 0126Z0 0,45%
ARCUTIS BIOTHERAPEUTICS I ARQT 0,39%
RHYTHM PHARMACEUTICALS IN RYTM 0,37%
BIO-RAD LABORATORIES-A BIO 0,3%
KINIKSA PHARMACEUTICALS I KNSA 0,29%
BRISTOL-MYERS SQUIBB CO BMY 0,27%
TARSUS PHARMACEUTICALS IN TARS 0,27%
BEONE MEDICINES LTD-ADR ONC 0,25%
NEUROGENE INC NGNE 0,22%
FIRST TRACKS BIOTHERAPEUT TRAX 0,2%
GENEDX HOLDINGS CORP WGS 0,13%
WAVE LIFE SCIENCES LTD WVE 0,12%
RECURSION PHARMACEUTICALS RXRX 0,08%
OMNIAB INC - 15.00 EARNOU 2200964 0%
OMNIAB INC - 12.5 EARNOUT 2200963 0%
Net Current Assets — -0,04%
Alle anzeigen Verstecken
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.